These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 605650
1. Immunization of NMRI mice against virulent Toxoplasma gondii. Differing efficacy of eleven cyst-forming Toxoplasma strains. Masihi KN, Werner H. Z Parasitenkd; 1977 Dec 29; 54(3):209-16. PubMed ID: 605650 [Abstract] [Full Text] [Related]
2. Delayed secondary immune response in mice immunized with Toxoplasma antigens and its effect for protection against Toxoplasma gondii. Yano K, Nakabayashi T. Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar 29; 256(3):381-9. PubMed ID: 6730784 [Abstract] [Full Text] [Related]
3. [Cellular immune reactions of the white mouse after superinfection with Toxoplasma gondii (author's transl)]. Pelster B. Z Parasitenkd; 1975 Dec 23; 48(2):95-110. PubMed ID: 1082685 [Abstract] [Full Text] [Related]
4. Experimental toxoplasmosis in mice and rabbits. Virulence and cyst formation of Toxoplasma gondii. Pettersen EK. Acta Pathol Microbiol Scand B; 1977 Feb 23; 85B(1):95-102. PubMed ID: 842354 [Abstract] [Full Text] [Related]
5. Attenuation of the virulent RH strain of Toxoplasma gondii by passages in mice immunized with Toxoplasma lysate antigens. Yano K, Nakabayashi T. Biken J; 1986 Jun 23; 29(2):31-7. PubMed ID: 3814072 [Abstract] [Full Text] [Related]
6. Chemiluminescence response of peritoneal exudate cells from mice infected with virulent and avirulent strains of Toxoplasma gondii. Masihi KN, Werner H, Gillert KE, Lange W. Parasite Immunol; 1984 May 23; 6(3):235-41. PubMed ID: 6739120 [Abstract] [Full Text] [Related]
7. Immunizing efficacy of Toxoplasma gondii strains isolated from different hosts. Masihi KN, Werner H, Lange W. Comp Immunol Microbiol Infect Dis; 1984 May 23; 7(2):125-30. PubMed ID: 6499407 [Abstract] [Full Text] [Related]
8. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells. Nakano Y, Hisaeda H, Sakai T, Zhang M, Maekawa Y, Zhang T, Nishitani M, Ishikawa H, Himeno K. Immunology; 2001 Nov 23; 104(3):289-98. PubMed ID: 11722643 [Abstract] [Full Text] [Related]
15. Vaccines against Toxoplasma gondii: challenges and opportunities. Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E. Mem Inst Oswaldo Cruz; 2009 Mar 23; 104(2):252-66. PubMed ID: 19430651 [Abstract] [Full Text] [Related]
16. Assessment in vitro of immunity against Toxoplasma gondii. Jones TC, Len L, Hirsch JG. J Exp Med; 1975 Feb 01; 141(2):466-82. PubMed ID: 1113065 [Abstract] [Full Text] [Related]
18. [The relationship between the fate of the agent of toxoplasmosis, Toxoplasma gondii, in macrophages cultivated in vitro and the virulence of the parasites]. Akinshina GT, Abakarova EG, Kirillova FM. Biull Eksp Biol Med; 1975 Nov 01; 80(11):60-3. PubMed ID: 1240782 [Abstract] [Full Text] [Related]
19. Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine. Overnes G, Nesse LL, Waldeland H, Lövgren K, Gudding R. Vaccine; 1991 Jan 01; 9(1):25-8. PubMed ID: 2008796 [Abstract] [Full Text] [Related]
20. Vaccination with Toxoplasma gondii calcium-dependent protein kinase 6 and rhoptry protein 18 encapsulated in poly(lactide-co-glycolide) microspheres induces long-term protective immunity in mice. Zhang NZ, Xu Y, Wang M, Chen J, Huang SY, Gao Q, Zhu XQ. BMC Infect Dis; 2016 Apr 18; 16():168. PubMed ID: 27090890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]